Search

Search Constraints

You searched for: Author/Creator Endo, Makoto

Search Results

2. A phase 1 trial of NY‐ESO‐1‐specific TCR‐engineered T‐cell therapy combined with a lymph node‐targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma. Issue 12 (17th February 2023)

3. Activation of the Akt‐mTOR pathway and receptor tyrosine kinase in patients with solitary fibrous tumors. Issue 6 (18th December 2013)

4. Activation of the Akt‐mTOR pathway and receptor tyrosine kinase in patients with solitary fibrous tumors. Issue 6 (18th December 2013)

6. Chimeric antigen receptor T-cell therapy targeting a MAGE A4 peptide and HLA-A*02:01 complex for unresectable advanced or recurrent solid cancer: protocol for a multi-institutional phase 1 clinical trial. Issue 11 (14th November 2022)

7. Class III β-Tubulin Overexpression Induces Chemoresistance to Eribulin in a Leiomyosarcoma Cell Line. (21st June 2018)

8. Clinical benefits of vessel sealing system (LigaSure™) during surgery for soft tissue sarcoma: a propensity score matching analysis. (28th May 2021)

9. Dedifferentiated liposarcoma in the extremity and trunk wall: A multi-institutional study of 132 cases by the Japanese Musculoskeletal Oncology Group (JMOG). Issue 2 (February 2023)

10. Efficacy and safety of tranexamic acid in patients undergoing surgery for bone and soft tissue tumors: a propensity score matching analysis. (9th May 2022)